Delivery Order SPE2DX22D0079-SPE2D826FABM4
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $61,909.60 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by January 13, 2026 and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., has been awarded a delivery order valued at $4,880.86 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,157.17 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and calls for performance in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $3,337.70 on January 9, 2026, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as a firm fixed-price delivery order with no set-aside designation, has an ultimate completion date of January 12, 2026. The work will be performed at Amerisourcebergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task order under...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at approximately $242,000 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, designated as a child order under a larger indefinite delivery contract vehicle, has an ultimate completion date of January 13, 2026 and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $46,035 on January 13, 2026, by the Defense Logistics Agency's Medical Supply Chain to supply pharmaceutical products and medical supplies. The contract is a firm fixed-price delivery order with an ultimate completion date of January 14, 2026, and represents work to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made on a non-set-aside, fully...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $4,049.10 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,144.41 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a child contract under a larger indefinite delivery vehicle and was competitively awarded without set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $36,824.76 by the Defense Logistics Agency's Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 12, 2026. This non-set-aside contract is a child order under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $3,751.44 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. The contract is non-competitive and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D826FABM4Delivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $4,491.84 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on January 13, 2026, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent company, Cencora, Inc., also maintains a substantial IDC with the Defense Logistics Agency valued up to $999,999,999.00 through December 31, 2031, underscoring the company's significant role in supporting Department of Defense medical procurement requirements. These contracts enable the company to supply essential pharmaceutical products to military treatment facilities, Veterans Affairs programs, and other federal medical institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 1/11/26 |